Verrica
West Chester, United States · Biotechnology, Healthcare, Health Care
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there’s a better way to safely and effectively bring relief to patients, deliver peace of mind to parents and caregivers, and advance accessible therapies to prescribers and payers. We are focused on changing the narrative around skin diseases and
Key facts
- Headquarters
- West Chester, United States
- Employees
- 76
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (VRCA)
- Website
- verrica.com
- Company page
Recent activity at Verrica
- : Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
- : Verrica Pharmaceuticals
- : SEC 8-K (1.01): On November 23, 2025, Verrica Pharmaceuticals, Inc. entered into two Securities Purchase Agreements to conduct a private placement transaction with institutional and accredited investors. The Company agreed to sell approximately 6.5 million shares of common stock along with pre-funded warrants for approximately 5.3 million shares and Series C warrants for around 2.9 million shares. This financing is intended to support the Company's ongoing operations and strategic initiatives. The move is significant as it provides the necessary capital for future growth, while also involving a considerable number of convertible instruments that could affect the Company's share structure.
- : Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
- : Verrica Pharmaceuticals Inc.
- : Verrica Pharmaceuticals Inc.
- : Verrica Pharmaceuticals Inc.
Verrica funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Venture | $50.0M |
| Feb 2018 | Venture | $20.0M |
| Dec 2017 | Venture | $5.0M |
| Dec 2015 | Venture | $2.4M |
Leadership
- Jeff, Regional Sales Director, West
- Richard, Regional Sales Director
- Matthew Davidson, Executive Officer, Director, Promoter
- Glenn Oclassen, Director, Promoter
- Jayson Rieger, Executive Officer, Director, Promoter
- Sean Stalfort, Director, Promoter
- Paul Manning, Director, Promoter
- Glenn Oclassen, Director, Promoter
- Paul Manning, Executive Officer, Director, Promoter
- Jayson Rieger, Executive Officer, Director, Promoter
- Sean Stalfort, Director, Promoter
- Matthew Davidson, Executive Officer, Director, Promoter
Verified email and direct lines for Verrica’s decision-makers are on Fundz. See plans
Verrica in the news
- Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences - GlobeNewswire (Sep 30, 2026)
- Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire (Sep 08, 2026)
- Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences - GlobeNewswire (Sep 10, 2026)
- Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - Business Wire (Mar 19, 2026)
- Ycanth Phase 3 Trial Dosing Begins for Common Warts in US, Japan - Dermatology Times (Jun 22, 2026)
- Verrica Pharmaceuticals to Report Second Quarter 2026 - GlobeNewswire (Jul 30, 2026)
- FDA Approves VP-102 for Molluscum Contagiosum - HCPLive (Jul 21, 2023)
- Verrica Announces Positive Preliminary Topline Results From Part 2 of Phase 2 Study of VP-315 for BCC - Dermatology Times (Aug 14, 2024)
Companies similar to Verrica
- Biofrontera · Biotechnology, Healthcare, Health Care, Therapeutics
- Passage Bio · Biotechnology, Healthcare, Health Care, Therapeutics
- Geneoscopy · Biotechnology, Healthcare, Health Care, Therapeutics
- QurAlis · Biotechnology, Healthcare, Health Care, Therapeutics
- Verastem Oncology · Biotechnology, Healthcare, Health Care, Therapeutics
About Verrica: questions and answers
What does Verrica do?
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there’s a better way to safely and effectively bring relief to patients, deliver peace of mind to parents and caregivers, and advance accessible therapies to prescribers and payers. We are focused on changing the narrative around skin diseases and
Where is Verrica headquartered?
Verrica is headquartered in West Chester, United States.
How many employees does Verrica have?
Verrica has about 76 employees.
Has Verrica raised funding?
Yes. Fundz has recorded 4 funding events for Verrica. The most recent, $50.0M, was in Dec 2025.
What is the latest news on Verrica?
On Feb 12, 2026, Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
Is Verrica a public company?
Yes. Verrica is publicly traded under the ticker VRCA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy